Perry Spratt

Company: Regel Therapeutics

Job title: Program Director - In Vivo Preclinical Programs

Seminars:

Advancing Gene Editing Technologies to Treat CNS Disorders 1:00 pm

Reviewing the current state of play for CNS-directed gene editing therapies Gene editing techniques to improve gene editing efficiency in the brain Debating viral vs non-viral approaches when delivering gene editing technologies to the brain Minimizing potential in vivo toxic effects of gene editing machinery to the brain Articulating the challenges surrounding fitting gene editing…Read more

day: Pre-Conf Workshop Track A PM